Investor's Business Daily on MSN4h
ARS Pharma Jumps After Inking $145 Million Deal For Epinephrine Nasal SprayARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback